Page 2 - Read Online
P. 2
Topic: Research on the Risk
Factors of Liver Cirrhosis
Complicated with HCC
Liver cancer is predicted to be the sixth most commonly
diagnosed cancer and the second leading cause of cancer
death worldwide now, with about one million new cases
and deaths each year. In general, hepatocellular carcinoma
(HCC) develops on the basis of chronic liver diseases,
mostly associated to liver cirrhosis as an important
pathogenic risk factor. There are several viral, non-viral,
metabolic, environmental and genetic factors, including
actually NAFLD and NASH liver disease, thus causing
the significant increase of HCC worldwide. Therefore, it
is absolutely meaningful to have a journal concentrated
on special scientific topics relevant to liver cancer in the
continuous publication model based on the present data
globally.
As far as I know, Hepatoma Research is the first internationally
peer-reviewed, continuously online published journal
focusing on liver cancer and related studies. The publication
Guido Gerken, MD model of the journal in a continuous way is distinguished
Professor of medicine, University of from other quarterly publication journals in this field.
Duisburg-Essen, Besides, the journal has gathered numerous internationally
Past CEO of the department of recognized experts joining the journal as EBM, especially
Hepatogastroenterology of the from high-incidence areas for HCC, e.g., Far East Asia,
University Hospital of Essen, FRG and especially from China. Most papers in the journal are
Senior Consultant both of Helios reviews from experts in the field and original scientific
clinic of Velbert-Essen, FRG and
Hyssens-Stiftung academic hospital articles on HCC mainly including carcinogenic mechanism,
of Essen-Mitte, FRG diagnosis, treatment, prevention and epidemiology of liver
Scientific consultant of the medical cancer undergoing strict peer-review. The special issue of
faculty of the University of Bielefeld, this HCC journal focuses on special topics, like Metabolic
FRG Syndrome, Prediction Models for HBV, Viral, Non-viral and
Vascular Risk Factors, Nutritional Status, Molecular and
Genomic Classification and Biomarkers in HCC diagnostics.
Finally, I feel very privileged and personally honored to act
as Guest Editor in this special issue of Hepatoma Research,
and thanks to all who have excellently contributed to the
HCC topics in this special issue.
